Tumor necrosis factor inhibitor-induced serositis.

MLA

Annapureddy, Narender, et al. “Tumor Necrosis Factor Inhibitor-Induced Serositis.” American Journal of Therapeutics, vol. 21, no. 5, Sept. 2014, pp. e166–68. EBSCOhost, https://doi.org/10.1097/MJT.0b013e31826fc4d1.

APA

Annapureddy, N., Agarwal, S. K., Ammakkanavar, N., Kanakadandi, V., Sabharwal, M. S., Sanjani, H. P., Simoes, P., & Nadkarni, G. N. (2014). Tumor necrosis factor inhibitor-induced serositis. American Journal of Therapeutics, 21(5), e166–e168. https://doi.org/10.1097/MJT.0b013e31826fc4d1

Chicago

Annapureddy, Narender, Shiv Kumar Agarwal, Natraj Ammakkanavar, Vijay Kanakadandi, Manpreet S Sabharwal, Hari Priya Sanjani, Priya Simoes, and Girish N Nadkarni. 2014. “Tumor Necrosis Factor Inhibitor-Induced Serositis.” American Journal of Therapeutics 21 (5): e166–68. doi:10.1097/MJT.0b013e31826fc4d1.